Risk of Vaccinia Transfer to the Hands of Vaccinated Persons after Smallpox Immunization
Open Access
- 15 February 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (4) , 536-541
- https://doi.org/10.1086/381205
Abstract
Transmission of vaccinia virus after smallpox vaccination is a concern. We conducted a prospective examination of the protection afforded by vaccination-site bandages in recently vaccinated individuals. After smallpox vaccination, inoculation sites were covered with 2 occlusive dressings. Site assessment and bandage changes occurred every 3–5 days until the site was healed. At each visit, specimens from the vaccination site, outer dressing surface, and contralateral hand were obtained for vaccinia culture. For 148 vaccinated subjects, vaccinia was detected from vaccination lesions of every subject on several occasions. Only 6 (0.65%) of 918 dressing (95% CI, 0.24%–1.4%) and 2 (0.22%) of 926 hand (95% CI, 0.03%–0.78%) specimens tested positive for vaccinia. The mean number of bandage changes was 9.6 (95% CI, 9.17–10.0). Vaccinia autoinoculation did not occur. The rate of vaccinia recovery outside occlusive bandages covering smallpox vaccination sites was remarkably low, suggesting excellent protection against inadvertent transmission.Keywords
This publication has 8 references indexed in Scilit:
- US Military Smallpox Vaccination Program ExperienceJAMA, 2003
- Smallpox and Smallpox VaccinationNew England Journal of Medicine, 2003
- Smallpox Vaccination in 2003: Key Information for CliniciansClinical Infectious Diseases, 2003
- How Contagious Is Vaccinia?New England Journal of Medicine, 2003
- Contact Vaccinia—Transmission of Vaccinia From Smallpox VaccinationJAMA, 2002
- Smallpox as a Biological WeaponJAMA, 1999
- Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical TrialThe Journal of Infectious Diseases, 1992
- Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinThe Lancet, 1991